Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 5,780.00
-260.00 (-4.30%)
Apr 30, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 371.7 billion as of April 30, 2026. Its market cap has decreased by -12.12% in one year.
Market Cap
371.70B
Enterprise Value
424.72B
Revenue
90.90B
Ranking
n/a
PE Ratio
40.54
Stock Price
5,780.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 371.70B, a decrease of -17.66%. That is a compound annual growth rate of -4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 371.70B | 20.08% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seegene | 1.16T |
| ToolGen | 750.78B |
| WON TECH | 681.04B |
| Curexo | 679.96B |
| i-SENS | 608.45B |
| InBody Co.,Ltd | 393.47B |
| DRTECH | 158.61B |
| T&R Biofab | 140.80B |